Pharmaceutical Services for Innovative Drugs

1.CDMO business of new drug Intermediates (Lab Grams-kg R & D Sample Supply, Process Optimization, cGMP & nGMP Scale-up Production)

2. Entrusted development of innovative drug CMC (including salt form and crystal form), non-clinical studies, assistance in pre-IND meeting application until IND license is obtained

3.Phase I, phase II clinical services for innovative drugs

4.Entrusted development services for Category 2 innovative drugs.

Nanjing Vcare provides from the supply of critical intermediates to CMC studies (including crystal form, salt form studies, drug substance synthesis, dosage form and strength confirmation), non-clinical studies, assists in pre-IND, meeting application and registration dossier submission until IND license is obtained, and can continue to serve the development of clinical phase I-II studies, and the whole lifecycle process of new drugs.